Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies



Rating:

Share or cite this content

Citations should be made in the following way:
F. Piffer, A. Airoldi, M. Di Pasquale, G. Pizzamiglio, M. Zanardelli, S. Galbiati, B. Dallari, F. Blasi (Milano, Italy). KL-6 serum levels in adult cystic fibrosis patients. Eur Respir J 2011; 38: Suppl. 55, 4288

Member's Comments

No comment yet.

Related content which might interest you: Serum lipid concentrations and malnutrition in adult cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 58s Year: 2006 Serial change in serum KL-6 levels correlate with the pulmonary function variables in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Relation of serum IGF-1 and IGFBP3 levels with acute exacerbation in cystic fibrosis Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018 Serum KL-6 identifies ILD patients with a progressive fibrosing phenotype Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Serum microRNA levels in paediatric females versus males with cystic fibrosis Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Elevated glucose concentrations in respiratory droplets of cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 527s Year: 2002 Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 KL-6 compared to LDH as a prognostic factor in Caucasian patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Sputum and plasma adiponectin levels in clinically stable adult cystic fibrosis patients with CFTR I1234V mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Source: Annual Congress 2004 - Fibrosing lung diseases Year: 2004 Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Myeloperoxidase and lactoferrin in serum of children with exacerbation of cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 126s Year: 2001 Serum and BALF levels of YKL-40 in patients with alveolar proteinosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005 High level of serum SP-D with normal range of KL-6 predicts a good prognosis of patients with fibrotic changes on HRCT Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018